TrialAlimentary pharmacology & therapeutics2017

Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy.

J-F Colombel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.